Stanford Researcher: COVID-19 Fatalities For Those Under 70 Are .04%


Once in a century FIASCO says Dr. Ionnidis

Dr. John Ionnidis, of Stanford University, was a co-author of a Coronavirus fatality rate study that revealed the fatality rate from COVID-19 in those under 70 years of age was just .04%. In an interview conducted with him by CNN News says that the latest study includes areas considered to be “pandemic epicenters.”

Among people <70 years old, infection fatality rates ranged from 0.00% to 0.26% with median of 0.05% (corrected, 0.00-0.23% with median of 0.04%). Most studies were done in pandemic epicenters and the few studies done in locations with more modest death burden also suggested lower infection fatality rates.

Dr. Ionnidis has been condemned for his expressed views that our reaction to this virus has not been appropriate. In a letter addressing concerns about his work, Dr. Ionnidis stated on May 22nd that the global response to the VOVID-19 pandemic could be “a once-in-a-century fiasco.”

Dr. Ionnidis has been called a “Prophet of Scientific Rigor” and a “COVID Contrarian,” by Wired.

Ioannidis has been a fixture in medical-school curricula for years, achieving something akin to hero status. He’s one of the most-cited scientists of any type in the world, and may be peerless on this metric among physicians. Amazingly, he’s earned all this acclaim by dedicating his career to telling the fields of biomedicine (and others, too) how shoddy they are, and how little trust one should have in their published research.

Despite the praise heaped on him by Wired author, David H. Freedman, the article says that while Ionnidis has laid bare the “foibles of medical science,” “medical science is returning the favor. Freedman argues that other researches believe his work on COVID-19 fatality rates are flawed. Ionnidis continues to stand by his and his colleagues’ work.

The conclusion of the fatality studies released on 8 June on with the permission of Ionnidis, states:

The infection fatality rate of COVID-19 can vary substantially across different locations and this may reflect differences in population age structure and case-mix of infected and deceased patients as well as multiple other factors. Estimates of infection fatality rates inferred from seroprevalence studies tend to be much lower than original speculations made in the early days of the pandemic.

“Group Think?”